Skip to main content
. Author manuscript; available in PMC: 2016 Jun 30.
Published in final edited form as: J Am Chem Soc. 2003 Nov 5;125(44):13382–13386. doi: 10.1021/ja030087z

Table 2.

Bioactivity of Manadomanzamines A, B and Xestomanzamine Aa

anti-TB
anti-HIV-1
antifungal IC50 (μg/mL)
MIC
(μg/mL)
EC50
(μg/mL)
Candida
albicans
Cryptococcus
neoformans
cytotoxicity IC50 (μg/mL)
compd A-594 H-116
manadomanzamine A 1.9 7.0 20 NA 2.5 5.0
manadomanzamine B 1.5 16.5 NA 3.5 >5 5.0
xestomanzamine A 14.1 11.2 NA 6.0 >5 >5
a

A-594 = human lung carcinoma; H-116 = human colon carcinoma; NA = not active.